MPM Asset Management

MPM Capital, now operating as MPM BioImpact, is a prominent life sciences venture capital firm dedicated to transforming healthcare through innovative biotechnology investments. Founded in 1996, the firm specializes in creating and investing in companies that develop breakthrough therapies for diseases with high unmet needs, particularly in oncology and immunology. MPM is distinguished by its active company-building approach, often providing the initial capital and executive leadership to translate academic research into clinical-stage startups. The firm manages a diverse portfolio across venture capital and public equities, leveraging a deep bench of scientific and clinical expertise to drive medical advancement. Through its various investment vehicles, including the Oncology Impact Fund, MPM has been instrumental in the development of numerous FDA-approved drugs.